Health&Life Co EBIT per Share
The EBIT per Share of Health&Life Co (1781.TWO) as of Sep 27, 2026 is -1.40 TWD. In the previous year, EBIT per Share was 0.63 TWD — a change of -322.65% (lower).
Get this data via API
Financial Data API
EBIT per Share
-1.40TWD
YoY
-322.65%
Last updated:
EBIT per Share of Health&Life Co is 2026 -1.40 TWD. EBIT per Share of Health&Life Co was 2025 0.63 TWD. It decreases by -322.65% lower compared to the previous year.
The Health&Life Co EBIT per Share history
3 Years
10 Years
25 Years
Max
EBIT per Share
Date
EBIT per Share
Jan 1, 2018
-1.20 TWD
Jan 1, 2019
-1.65 TWD
Jan 1, 2020
-0.35 TWD
Jan 1, 2021
-2.04 TWD
Jan 1, 2022
-0.95 TWD
Jan 1, 2023
-0.84 TWD
Jan 1, 2024
0.63 TWD
Jan 1, 2025
-1.40 TWD
| YEAR | EBIT per Share | YoY |
|---|---|---|
| -1.40TWD | -322.65% | |
| 0.63TWD | -174.28% | |
| -0.84TWD | -11.26% | |
| -0.95TWD | -53.47% | |
| -2.04TWD | +477.50% | |
| -0.35TWD | -78.59% | |
| -1.65TWD | +37.35% | |
| -1.20TWD | -13.35% | |
| -1.39TWD | -15.82% | |
| -1.65TWD | -10.47% | |
| -1.84TWD | -2.39% | |
| -1.89TWD | -625.19% | |
| 0.36TWD | -81.50% | |
| 1.94TWD | -282.93% | |
| -1.06TWD | -148.13% | |
| 2.21TWD | -395.72% | |
| -0.75TWD | -58.70% | |
| -1.81TWD | -310.71% | |
| 0.86TWD | -137.86% | |
| -2.27TWD | — |
Access this data via the Eulerpool API
Health&Life Co Stock analysis
What does Health&Life Co do? Health&Life Co is one of the most popular companies on Eulerpool.
Frequently Asked Questions about Health&Life Co stock
EBIT per Share of Health&Life Co is -1.40 TWD in 2026.
EBIT per Share of Health&Life Co changed from 0.63 TWD to -1.40 TWD, representing a -322.65% change. The value is lower than the previous year.
On Eulerpool you can find the complete historical development of EBIT per Share Health&Life Co since 2006 – with annual values, charts, and detailed analysis.
EBIT per Share measures operating profit allocated to each outstanding share.
Access this data via the Eulerpool API
Income Statement — Health&Life Co
All Key Metrics — Health&Life Co
Valuation
Income Statement
Margins
Balance Sheet
- Total Assets
- Current Assets
- Cash & Equivalents
- Receivables
- Inventory
- Property, Plant & Equipment
- Goodwill
- Intangible Assets
- Equity
- Liabilities
- Debt
- Current Liabilities
- Long-term Debt
- Short-term Debt
- Retained Earnings
- Book Value per Share
- Tangible Book Value per Share
- Working Capital
- Investments
- Accounts Payable
- Non-Current Assets
- Short-Term Investments
- Long-Term Investments
- Net Debt
- Treasury Stock
- Minority Interest
- Deferred Tax Liabilities
- Net Tangible Assets
- Goodwill/Assets
- Intangibles/Assets
Cash Flow
- Operating Cash Flow
- Capital Expenditures
- Free Cash Flow
- FCF per Share
- Dividends Paid
- Share Buybacks
- Investing Cash Flow
- Financing Cash Flow
- CapEx / Revenue
- Cash Flow per Share
- Stock-Based Compensation
- Change in Working Capital
- Acquisitions (Net)
- Net Change in Cash
- CapEx/OCF
- FCF/Net Income
- FCF Conversion
- Cash Conversion
- Total Shareholder Payout
- CapEx/D&A
Profitability
- ROE
- ROA
- ROCE
- ROIC
- Asset Turnover
- Inventory Turnover
- Receivables Turnover
- Days Sales Outstanding
- Days Inventory Outstanding
- Days Payable Outstanding
- Cash Conversion Cycle
- CROIC
- Gross Profit/Assets
- Fixed Asset Turnover
- Equity Turnover
- Working Capital Turnover
- Payables Turnover
- Capital Intensity
- Receivables/Revenue
- Inventory/Revenue
- EBIT/Assets
Leverage
Growth
- Revenue Growth
- Revenue CAGR 3Y
- Revenue CAGR 5Y
- Revenue CAGR 10Y
- Earnings Growth
- EPS Growth
- EBIT Growth
- EBIT CAGR 3Y
- EBIT CAGR 5Y
- EBIT CAGR 10Y
- Dividend Growth
- FCF Growth
- Book Value Growth
- Earnings CAGR 3Y
- Earnings CAGR 5Y
- Earnings CAGR 10Y
- EPS CAGR 3Y
- EPS CAGR 5Y
- EBITDA Growth YoY
- EBITDA CAGR 3Y
- EBITDA CAGR 5Y
- Gross Profit Growth
- OCF Growth YoY
- Employee Growth
- Dividend CAGR 3Y
- Dividend CAGR 5Y
- Dividend CAGR 10Y
- Asset Growth
- Equity Growth
- Debt Growth
- CapEx Growth
- FCF CAGR 3Y
- FCF CAGR 5Y
- Market Cap Growth
- Share Count Growth